🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07330362
Recruiting Observational

The Clinical Application of Artificial Intelligence Assisted Renal Biopsy Diagnosis System.

NCT07330362 · tracked via the Priya Life Science China tracker
Sponsor
Zhujiang Hospital
Phase
Observational
Started
2024-07-01
Last updated
2026-01-27

Condition(s) studied

Chronic GlomerulonephritisChronic Kidney Disease

Study summary

This research project aims to collect images from patients with chronic glomerulonephritis. For each subject, the images obtained from renal biopsy will undergo evaluation by both the diagnostic model and the 'gold standard' diagnosis by pathologists. The researchers will test the subjects using the diagnostic model and compare the results with the known 'gold standard' diagnosis, in order to evaluate the AUC, specificity, and sensitivity of the diagnostic model.

Eligibility

Sex
ALL
Min age
15 Years
Max age
79 Years
Healthy volunteers
No
Inclusion Criteria: 1. Voluntary signing of informed consent form; 2. Patients clinically diagnosed or suspected of having chronic kidney disease according to the 2023 KDIGO Clinical Practice Guideline for the Evaluation and Management of Kidney Disease; 3. Undergoing renal biopsy and pathological specimen preparation. Exclusion Criteria: 1. Biopsy tissue from donor kidney or transplanted kidney; 2. Poor quality of pathological specimen, unable to conduct pathological diagnosis.

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Nanfang Hospital Guangzhou Guangdong Recruiting
Zhujiang Hospital of Southern Medical University Guangzhou Guangdong Recruiting

More Zhujiang Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07330362 on ClinicalTrials.gov ↗ ← All trials in China